Epsilon Protein kinase C (εPCK) is a particular kinase that, when activated, is able to protect against different stress injuries and therefore has been proposed to be a potential molecular target against acute and chronic diseases. Particular attention has been focused on εPCK for its involvement in the protective mechanism of Ischemic Preconditioning (IPC), a powerful endogenous mechanism characterized by subthreshold ischemic insults able to protect organs against ischemic injury. Therefore, in the past decades several εPCK modulators have been tested with the object to emulate εPCK mediate protection. Among these the most promising, so far, has been the ΨεRACK peptide, a homologous of RACK receptor for εPKC, that when administrated can mimic its effect in the cells. However, results from studies on εPCK indicate controversial role of this kinase in different organs and diseases, such as myocardial infarct, stroke, diabetes and cancer. Therefore, in this review we provide a discussion on the function of εPCK in acute and chronic diseases and how the different activators and inhibitors have been used to modulate its activity. A better understanding of its function is still needed to definitively target εPCK as novel therapeutic strategy.

Capuani, B., Pacifici, F., Pastore, D., Palmirotta, R., Donadel, G., Arriga, R., et al. (2016). The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators. PHARMACOLOGICAL RESEARCH, 111, 659-667 [10.1016/j.phrs.2016.07.029].

The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators

CAPUANI, BARBARA;PASTORE, DONATELLA;DONADEL, GIULIA;ARRIGA, ROBERTO;BELLIA, ALFONSO;DI DANIELE, NICOLA;ROGLIANI, PAOLA;SBRACCIA, PAOLO;LAURO, DAVIDE;DELLA MORTE, DAVID
2016

Abstract

Epsilon Protein kinase C (εPCK) is a particular kinase that, when activated, is able to protect against different stress injuries and therefore has been proposed to be a potential molecular target against acute and chronic diseases. Particular attention has been focused on εPCK for its involvement in the protective mechanism of Ischemic Preconditioning (IPC), a powerful endogenous mechanism characterized by subthreshold ischemic insults able to protect organs against ischemic injury. Therefore, in the past decades several εPCK modulators have been tested with the object to emulate εPCK mediate protection. Among these the most promising, so far, has been the ΨεRACK peptide, a homologous of RACK receptor for εPKC, that when administrated can mimic its effect in the cells. However, results from studies on εPCK indicate controversial role of this kinase in different organs and diseases, such as myocardial infarct, stroke, diabetes and cancer. Therefore, in this review we provide a discussion on the function of εPCK in acute and chronic diseases and how the different activators and inhibitors have been used to modulate its activity. A better understanding of its function is still needed to definitively target εPCK as novel therapeutic strategy.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/13 - Endocrinologia
Settore MED/09 - Medicina Interna
Settore MED/04 - Patologia Generale
eng
Con Impact Factor ISI
Acute diseases; Cancer; Chronic diseases; Epsilon PKC; Epsilon PKC modulators; Ischemic preconditioning; Metabolism, Diabetes Mellitus
Capuani, B., Pacifici, F., Pastore, D., Palmirotta, R., Donadel, G., Arriga, R., et al. (2016). The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators. PHARMACOLOGICAL RESEARCH, 111, 659-667 [10.1016/j.phrs.2016.07.029].
Capuani, B; Pacifici, F; Pastore, D; Palmirotta, R; Donadel, G; Arriga, R; Bellia, A; Di Daniele, N; Rogliani, P; Abete, P; Sbraccia, P; Guadagni, F; Lauro, D; Della-Morte, D
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
The role of epsilon PKC i 2016.pdf

non disponibili

Licenza: Copyright dell'editore
Dimensione 1.33 MB
Formato Adobe PDF
1.33 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/162171
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact